NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 73 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,604,294 | -18.3% | 1,457,055 | 0.0% | 0.11% | -40.7% |
| Q2 2023 | $5,638,803 | +39.7% | 1,457,055 | 0.0% | 0.18% | +26.4% |
| Q1 2023 | $4,036,042 | +153771.2% | 1,457,055 | 0.0% | 0.14% | +82.3% |
| Q4 2022 | $2,623 | -99.9% | 1,457,055 | 0.0% | 0.08% | +43.6% |
| Q3 2022 | $3,089,000 | -21.2% | 1,457,055 | 0.0% | 0.06% | -36.0% |
| Q2 2022 | $3,919,000 | -38.0% | 1,457,055 | 0.0% | 0.09% | +16.2% |
| Q1 2022 | $6,324,000 | -16.2% | 1,457,055 | 0.0% | 0.07% | +68.2% |
| Q4 2021 | $7,548,000 | -15.6% | 1,457,055 | 0.0% | 0.04% | -97.6% |
| Q3 2021 | $8,946,000 | -39.2% | 1,457,055 | 0.0% | 1.82% | -52.6% |
| Q2 2021 | $14,716,000 | – | 1,457,055 | – | 3.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
| Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
| AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
| Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
| Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
| Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
| HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
| RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |